COVID-19 Q&A on dealing with pandemic fatigue
“We need to strike a balance and take our anxiety down from an unhealthy to a manageable level,” says researcher Jason Harley
New study shows that persistence of ADHD into adulthood is an important predictor of car crash risk
RI-MUHC researcher Dr. Lily Hechtman is senior author of a 20-year study
Research suggests greater access to specific HIV and tuberculosis medications is needed worldwide
Postdoctoral fellows at the RI-MUHC carried out primary statistical analyses for study published in The Lancet
Inappropriate prescriptions sending hospitalized seniors back to the ER
Improving hospital prescribing practices may reduce risk of rehospitalization and death
The World Brain Death Project: New publication offers significant and unprecedented consensus on the question of when brain death occurs
Dr. Sam Shemie offers a reference standard for practices worldwide
Study identifies strategies to reduce breast cancer growth and related skeletal lesions
RI-MUHC team publishes findings in the journal, Bone Research
Early treatment trial of hydroxychloroquine shows no symptomatic benefit for COVID-19 patients
Adult outpatients with mild symptoms of COVID-19 don’t benefit from taking hydroxychloroquine
Sodium found to regulate the biological clock of mice
New study by RI-MUHC researchers first to establish that physiological signals influence circadian rhythms
At the heart of precision medicine
New translational collaboration aims to transform approach to heart muscle disease
Novel gene therapy trial offers hope to patients with rare metabolic disease
Samuel is the first Canadian and the ninth patient worldwide to participate in the second phase of a study using gene...